Literature DB >> 20534349

The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility.

Selena M Sagan1, Neda Nasheri, Christian Luebbert, John Paul Pezacki.   

Abstract

Hepatitis C virus (HCV) is a global health problem. Designing therapeutic agents that target HCV's RNA genome remains challenging. HCV genomic RNA is large and highly structured with long-range genome-scale ordered RNA structures. Predicting the secondary- and tertiary-structure elements that reveal the accessibility of target sites within HCV RNA is difficult because of the abundance of long-range interactions. Target site accessibility remains a significant barrier to the design of effective therapeutics such as small interfering RNAs (siRNAs) against different strains of HCV. Here we developed two methods that interrogate the folding of HCV RNA, an approach involving viral RNA microarrays (VRMs) and an HCV viral RNA-coated magnetic bead-based (VRB) assay. VRMs and VRBs were used to determine target site accessibility for siRNAs designed against the HCV genome. Both methods predicted potency of siRNAs in cell-culture models for HCV replication that are not easily predicted by informatic means. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534349     DOI: 10.1016/j.chembiol.2010.04.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  12 in total

1.  Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

Authors:  Partha K Chandra; Anup K Kundu; Sidhartha Hazari; Sruti Chandra; Lili Bao; Tara Ooms; Gilbert F Morris; Tong Wu; Tarun K Mandal; Srikanta Dash
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

2.  Requirement for Host RNA-Silencing Components and the Virus-Silencing Suppressor when Second-Site Mutations Compensate for Structural Defects in the 3' Untranslated Region.

Authors:  Maitreyi Chattopadhyay; Vera A Stupina; Feng Gao; Christine R Szarko; Micki M Kuhlmann; Xuefeng Yuan; Kerong Shi; Anne E Simon
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

3.  Long-range architecture in a viral RNA genome.

Authors:  Eva J Archer; Mark A Simpson; Nicholas J Watts; Rory O'Kane; Bangchen Wang; Dorothy A Erie; Alex McPherson; Kevin M Weeks
Journal:  Biochemistry       Date:  2013-04-25       Impact factor: 3.162

4.  Antiviral RNA interference responses induced by Semliki Forest virus infection of mosquito cells: characterization, origin, and frequency-dependent functions of virus-derived small interfering RNAs.

Authors:  Ricky W C Siu; Rennos Fragkoudis; Peter Simmonds; Claire L Donald; Margo E Chase-Topping; Gerald Barry; Ghassem Attarzadeh-Yazdi; Julio Rodriguez-Andres; Anthony A Nash; Andres Merits; John K Fazakerley; Alain Kohl
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

5.  DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli.

Authors:  Yamei Liu; Victor G Stepanov; Ulrich Strych; Richard C Willson; George W Jackson; George E Fox
Journal:  BMC Biotechnol       Date:  2010-12-06       Impact factor: 2.563

6.  Enhanced inhibition of Avian leukosis virus subgroup J replication by multi-target miRNAs.

Authors:  Qing-Wen Meng; Zai-Ping Zhang; Wei Wang; Jin Tian; Zhi-Guang Xiao
Journal:  Virol J       Date:  2011-12-22       Impact factor: 4.099

7.  The influence of viral RNA secondary structure on interactions with innate host cell defences.

Authors:  Jeroen Witteveldt; Richard Blundell; Joris J Maarleveld; Nora McFadden; David J Evans; Peter Simmonds
Journal:  Nucleic Acids Res       Date:  2013-12-13       Impact factor: 16.971

8.  A magnesium-induced RNA conformational switch at the internal ribosome entry site of hepatitis C virus genome visualized by atomic force microscopy.

Authors:  Ana García-Sacristán; Miguel Moreno; Ascensión Ariza-Mateos; Elena López-Camacho; Rosa M Jáudenes; Luis Vázquez; Jordi Gómez; José Ángel Martín-Gago; Carlos Briones
Journal:  Nucleic Acids Res       Date:  2014-12-15       Impact factor: 16.971

9.  Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision.

Authors:  Hubert Denise; Sterghios A Moschos; Benjamin Sidders; Frances Burden; Hannah Perkins; Nikki Carter; Tim Stroud; Michael Kennedy; Sally-Ann Fancy; Cris Lapthorn; Helen Lavender; Ross Kinloch; David Suhy; Romu Corbau
Journal:  Mol Ther Nucleic Acids       Date:  2014-02-04       Impact factor: 10.183

10.  RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference.

Authors:  Julita Piasecka; Elzbieta Lenartowicz; Marta Soszynska-Jozwiak; Barbara Szutkowska; Ryszard Kierzek; Elzbieta Kierzek
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-24       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.